Mean (SD) improvement | ||||||
---|---|---|---|---|---|---|
Intervention | Control | Between-group difference † (95% CI) | p-value | |||
6 months | PT (n = 62) | Pain | 2.0 (1.8) | 0.7 (1.6) | 1.4 (0.4 – 2.5) ‡ | 0.01 |
Functional status NPDI | 14 (21) | 8 (18) | 4.8 (-5.2 – 14.9) | 0.34 | ||
Functional status QBPDS | 13 (24) | 10 (21) | 2.4 (-9.9 – 14.8) | 0.70 | ||
PTCBWE (n = 102) | Pain | 1.5 (2.0) | 0.8 (2.0) | 0.7 (-0.1 – 1.5) | 0.09 | |
Functional status NPDI | 15 (16) | 9 (15) | 5.3 (-0.8 – 11.5) | 0.09 | ||
Functional status QBPDS | 13 (20) | 10 (14) | 2.7 (-4.0 – 9.5) | 0.43 | ||
12 months | PT (n = 67) | Pain | 2.3 (2.1) | 1.6 (2.8) | 0.9 (-1.2 – 1.4) | 0.90 |
Functional status NPDI | 17 (18) | 13 (24) | -1.2 (-11.9 – 9.4) | 0.82 | ||
Functional status QBPDS | 15 (20) | 16 (26) | -5.8 (-17.7 – 6.2) | 0.34 | ||
PTCBWE (n = 96) | Pain | 2.1 (2.1) | 2.0 (2.4) | 0.03 (-0.9 – 1.0) | 0.95 | |
Functional status NPDI | 16 (18) | 15 (18) | 0.8 (-6.3 – 7.9) | 0.83 | ||
Functional status QBPDS | 14 (20) | 14 (18) | -0.3 (-7.9 – 7.3) | 0.94 |